| The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications GG Van den Eynden, AW Majeed, M Illemann, PB Vermeulen, NC Bird, ... Cancer research 73 (7), 2031-2043, 2013 | 241 | 2013 |
| International consensus guidelines for scoring the histopathological growth patterns of liver metastasis PJ Van Dam, EP Van Der Stok, LA Teuwen, GG Van den Eynden, ... British journal of cancer 117 (10), 1427-1441, 2017 | 191 | 2017 |
| The morphological growth patterns of colorectal liver metastases are prognostic for overall survival K Nielsen, HC Rolff, RL Eefsen, B Vainer Modern Pathology 27 (12), 1641-1648, 2014 | 106 | 2014 |
| TNF receptor-2 facilitates an immunosuppressive microenvironment in the liver to promote the colonization and growth of hepatic metastases B Ham, N Wang, Z D'Costa, MC Fernandez, F Bourdeau, P Auguste, ... Cancer research 75 (24), 5235-5247, 2015 | 87 | 2015 |
| Growth pattern of colorectal liver metastasis as a marker of recurrence risk RL Eefsen, PB Vermeulen, IJ Christensen, OD Laerum, MB Mogensen, ... Clinical & experimental metastasis 32, 369-381, 2015 | 78 | 2015 |
| Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases RL Eefsen, GG Van den Eynden, G Høyer-Hansen, P Brodt, OD Laerum, ... Journal of oncology 2012, 2012 | 59 | 2012 |
| Tissue inhibitor of matrix metalloproteinase‐1 expression in colorectal cancer liver metastases is associated with vascular structures M Illemann, RHL Eefsen, NC Bird, A Majeed, K Osterlind, OD Laerum, ... Molecular carcinogenesis 55 (2), 193-208, 2016 | 24 | 2016 |
| The prognostic and predictive value of soluble type IV collagen in colorectal cancer: a retrospective multicenter study HC Rolff, IJ Christensen, B Vainer, LB Svendsen, RL Eefsen, ... Clinical Cancer Research 22 (10), 2427-2434, 2016 | 21 | 2016 |
| Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo‐adjuvant cytotoxic chemotherapy and bevacizumab RL Eefsen, L Engelholm, GL Willemoe, GG Van den Eynden, OD Laerum, ... International journal of cancer 138 (7), 1777-1784, 2016 | 21 | 2016 |
| Inflammation and uPAR-expression in colorectal liver metastases in relation to growth pattern and neo-adjuvant therapy RL Eefsen, L Engelholm, W Alpizar-Alpizar, GGE Van den Eynden, ... Cancer Microenvironment 8, 93-100, 2015 | 19 | 2015 |
| Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study S Ehmsen, LH Jakobsen, ME Lendorf, RL Eefsen, L Bentsen, AS Knoop, ... Acta Oncologica 60 (7), 859-865, 2021 | 7 | 2021 |
| Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer RL Eefsen, JS Larsen, LL Klarskov, R Altaf, E Høgdall, P Ingeholm, ... International Journal of Cancer 152 (10), 2145-2152, 2023 | 6 | 2023 |
| ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling–a national, phase 2, prospective, multi-drug, non-randomized, open-label … T Kringelbach, M Højgaard, K Rohrberg, I Spanggaard, BE Laursen, ... BMC cancer 23 (1), 182, 2023 | 5 | 2023 |
| Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with … E Van Cutsem, R Løvendahl Eefsen, S Ochsenreither, Z Zvirbule, ... J Clin Oncol 40, 4141, 2022 | 4 | 2022 |
| Comparison of Classical Dermatoscopy and Acrylic Globe Magnifier Dermatoscopy. HF Lorentzen, RL Eefsen, K Weismann Acta dermato-venereologica 88 (2), 2008 | 4 | 2008 |
| An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine I Kümler, RL Eefsen, PG Sørensen, S Theile, A Fullerton, PG Nielsen, ... Cancer Chemotherapy and Pharmacology 84, 441-446, 2019 | 3 | 2019 |
| Tumor Stromal Phenotypes Define VEGF Sensitivity GG Van den Eynden, NC Bird, LY Dirix, RL Eefsen, ZH Gao, ... Clinical Cancer Research 20 (19), 5140-5140, 2014 | 3 | 2014 |
| Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study … NJ Spindler, GF Persson, S Theile, DL Nielsen, EV Høgdall, G Al-Farra, ... BMJ open 13 (1), e063500, 2023 | 2 | 2023 |
| Genomic landscape of treatment refractory metastatic colorectal cancer RL Eefsen, KS Simonsen, P Grundtvig, L Klarskov, IM Chen, D Høgdall, ... Acta Oncologica 60 (12), 1621-1628, 2021 | 2 | 2021 |
| 538P Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell … AH Awada, M Zematis, S Ochsenreither, RL Eefsen, D Arnold, S Cicenas, ... Annals of Oncology 32, S602-S603, 2021 | 2 | 2021 |
